Sequence variants at the TERT-CLPTM1L locus associate with many cancer types (original) (raw)

References

  1. Stacey, S.N. et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat. Genet. 40, 1313–1318 (2008).
    Article CAS Google Scholar
  2. Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631–637 (2007).
    Article CAS Google Scholar
  3. Stacey, S.N. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 39, 865–869 (2007).
    Article CAS Google Scholar
  4. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645–649 (2007).
    Article CAS Google Scholar
  5. Haiman, C.A. et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat. Genet. 39, 638–644 (2007).
    Article CAS Google Scholar
  6. Easton, D.F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087–1093 (2007).
    Article CAS Google Scholar
  7. Tomlinson, I. et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39, 984–988 (2007).
    Article CAS Google Scholar
  8. Gudbjartsson, D.F. et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886–891 (2008).
    Article CAS Google Scholar
  9. Thorgeirsson, T.E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638–642 (2008).
    Article CAS Google Scholar
  10. Eeles, R.A. et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40, 316–321 (2008).
    Article CAS Google Scholar
  11. Hung, R.J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633–637 (2008).
    Article CAS Google Scholar
  12. Amos, C.I. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616–622 (2008).
    Article CAS Google Scholar
  13. Thomas, G. et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40, 310–315 (2008).
    Article CAS Google Scholar
  14. Kiemeney, L.A. et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40, 1307–1312 (2008).
    Article CAS Google Scholar
  15. Amundadottir, L.T. et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38, 652–658 (2006).
    Article CAS Google Scholar
  16. Haiman, C.A. et al. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet. 39, 954–956 (2007).
    Article CAS Google Scholar
  17. Gudbjartsson, D.F. et al. Many sequence variants affecting diversity of adult human height. Nat. Genet. 40, 609–615 (2008).
    Article CAS Google Scholar
  18. Yamamoto, K., Okamoto, A., Isonishi, S., Ochiai, K. & Ohtake, Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem. Biophys. Res. Commun. 280, 1148–1154 (2001).
    Article CAS Google Scholar
  19. Blackburn, E.H. Switching and signaling at the telomere. Cell 106, 661–673 (2001).
    Article CAS Google Scholar
  20. Wu, X. et al. Telomere dysfunction: a potential cancer predisposition factor. J. Natl. Cancer Inst. 95, 1211–1218 (2003).
    Article CAS Google Scholar
  21. Shen, J. et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 67, 5538–5544 (2007).
    Article CAS Google Scholar
  22. Widmann, T.A., Herrmann, M., Taha, N., Konig, J. & Pfreundschuh, M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp. Hematol. 35, 939–946 (2007).
    Article CAS Google Scholar
  23. Risques, R.A. et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 16, 2649–2655 (2007).
    Article CAS Google Scholar
  24. Han, J. et al. A prospective study of telomere length and the risk of skin cancer. J. Invest. Dermatol. advance online publication, doi: 10.1038/jid.2008.238 (31 July 2008).
  25. Zhang, A. et al. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int. J. Cancer 101, 427–433 (2002).
    Article CAS Google Scholar
  26. Kang, J.U., Koo, S.H., Kwon, K.C., Park, J.W. & Kim, J.M. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet. Cytogenet. 182, 1–11 (2008).
    Article CAS Google Scholar
  27. Tomlinson, I.P. et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet. 40, 623–630 (2008).
    Article CAS Google Scholar
  28. Valdes, A.M. et al. Obesity, cigarette smoking, and telomere length in women. Lancet 366, 662–664 (2005).
    Article CAS Google Scholar
  29. Frenck, R.W. Jr ., Blackburn, E.H. & Shannon, K.M. The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. USA 95, 5607–5610 (1998).
    Article CAS Google Scholar
  30. Slagboom, P.E., Droog, S. & Boomsma, D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 55, 876–882 (1994).
    CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We thank the individuals that participated in the study and whose contribution made this work possible. We also thank the nurses at deCODE's participant recruitment center and the personnel at deCODE's core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic subjects with cancer. The project was funded in part by the European Commission (POLYGENE: LSHC-CT-2005-018827 and GENADDICT: LSHM-CT-2004-005166), the National Institutes of Health (R01-DA017932) and a research investment grant of the Radboud University Nijmegen Medical Centre. The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: “Food Quality and Safety” (Contract No 513943); and by a grant of the compagnia di San Paolo, the Italian Association for Cancer Research, Italy and the Piedmont Region Progetti di Ricerca Sanitaria Finalizzata. J.H. is supported by the Swedish Cancer Society, The Radiumhemmet Research Funds, The Swedish Research Council and the Karolinska Institutet Research Funds.

Author information

Author notes

  1. Thorunn Rafnar and Patrick Sulem: These authors contributed equally to this work.

Authors and Affiliations

  1. deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
    Thorunn Rafnar, Patrick Sulem, Simon N Stacey, Frank Geller, Julius Gudmundsson, Asgeir Sigurdsson, Margret Jakobsdottir, Hafdis Helgadottir, Steinunn Thorlacius, Thorarinn Blöndal, Thorgeir E Thorgeirsson, Gudmar Thorleifsson, Kristleifur Kristjansson, Hjordis Bjarnason, Margret Asgeirsdottir, Kari T Kristinsson, Sigurborg Matthiasdottir, Michael L Frigge, Jeffrey R Gulcher, Gisli Masson, Daniel F Gudbjartsson, Augustine Kong, Unnur Thorsteinsdottir & Kari Stefansson
  2. Comprehensive Cancer Center East, BG, 6501, Nijmegen, The Netherlands
    Katja K H Aben & Lambertus A Kiemeney
  3. Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, HB, 6500, Nijmegen, The Netherlands
    Katja K H Aben, Femmie de Vegt & Lambertus A Kiemeney
  4. Department of Dermatology, University of Iceland, 101 Reykjavik, Iceland
    Kristin Thorisdottir, Bardur Sigurgeirsson & Jon H Olafsson
  5. Departments of Plastic Surgery, Landspitali-University Hospital, 101 Reykjavik, Iceland
    Rafn Ragnarsson
  6. Medical Oncology, Landspitali-University Hospital, 101 Reykjavik, Iceland
    Halla Skuladottir
  7. Surgery, Landspitali-University Hospital, 101 Reykjavik, Iceland
    Tomas Gudbjartsson & Thorvaldur Jonsson
  8. Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
    Tomas Gudbjartsson, Kristrun R Benediktsdottir, Bjarni A Agnarsson, Thorvaldur Jonsson, Steinn Jonsson, Jon H Olafsson, Unnur Thorsteinsdottir & Kari Stefansson
  9. Departments of Pathology, Landspitali-University Hospital, 101 Reykjavik, Iceland
    Helgi J Isaksson, Kristrun R Benediktsdottir, Bjarni A Agnarsson & Rosa B Barkardottir
  10. Urology, Landspitali-University Hospital, 101 Reykjavik, Iceland
    Gudmundur V Einarsson & Eirikur Jonsson
  11. Obstetrics and Gynecology, Landspitali-University Hospital, 101 Reykjavik, Iceland
    Karl Olafsson, Anna Salvarsdottir & Hafsteinn Saemundsson
  12. Clinical Research Centre, Krokhals 5D, 110 Reykjavik, Iceland
    Steinunn G Sveinsdottir
  13. ISI Foundation (Institute for Scientific Interchange), Torino, 10133, Italy
    Silvia Polidoro, Giuseppe Matullo & Paolo Vineis
  14. Department of Genetics, Biology and Biochemistry, University of Torino, Torino, 10126, Italy
    Silvia Polidoro & Giuseppe Matullo
  15. Department of Oncology-Pathology, Cancer Centre Karolinska, Karolinska Institutet, Karolinska University Hospital Solna Stockholm, S-171 76, Sweden
    Veronica Höiom, Gunnar Steineck & Johan Hansson
  16. Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, 46009, Spain
    Rafael Botella-Estrada & Eduardo Nagore
  17. Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, D-69120, Germany
    Kari Hemminki & Rajiv Kumar
  18. National Institute of Environmental Health, Budapest, H-1450, Hungary
    Peter Rudnai
  19. Section of Epidemiology & Biostatistics, Leeds Institute of Molecular Medicine, St. James's University Hospital, LS9 7TF, Leeds, UK
    D Timothy Bishop
  20. Department of Experimental and Applied Medicine - Section of Occupational Medicine and Industrial Hygiene, University of Brescia, Brescia, 25125, Italy
    Marcello Campagna & Stefano Porru
  21. Department of General Practice, Catholic University of Leuven, Leuven, 3000, Belgium
    Eliane Kellen & Frank Buntinx
  22. Leuven University Centre for Cancer Prevention (LUCK), Leuven, 3000, Belgium
    Eliane Kellen
  23. Department of Public Health and Epidemiology, Unit of Genetic Epidemiology, University of Birmingham, Birmingham, B15 2TT, UK
    Maurice P Zeegers
  24. Department of Complex Genetics, Cluster of Genetics and Cell Biology, Nutrition and Toxicology Research Institute, Maastricht University, MD, 6200, Maastricht, The Netherlands
    Maurice P Zeegers
  25. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, S171 76, Sweden
    Petra de Verdier & Annika Lindblom
  26. Division of Medical Oncology, University Hospital, 50009, Zaragoza, Spain
    Ana Ferrer, Dolores Isla, Maria Jesus Vidal, Raquel Andres, Alejandro Tres & José I Mayordomo
  27. Health Science Institute, Zaragoza, 50009, Spain
    Berta Saez
  28. Division of Dermatology, University Hospital, Zaragoza, 50009, Spain
    Pablo Juberias
  29. Divisions of Nuclear Medicine, University Hospital, Zaragoza, 50009, Spain
    Javier Banzo
  30. Radiation Oncology, University Hospital, Zaragoza, 50009, Spain
    Sebastian Navarrete
  31. Health Science Institute, Nanotechnology Institute of Aragon, Zaragoza, 50009, Spain
    Alejandro Tres & José I Mayordomo
  32. Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, 60611, Illinois, USA
    Donghui Kan & William J Catalona
  33. Environmental Health Center, Cluj Napoca, 400166, Romania
    Eugene Gurzau
  34. State Health Institute, SK-975 56 Banska Bystrica, Slovakia
    Kvetoslava Koppova
  35. Departments of Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, HB, 6500, Nijmegen, The Netherlands
    Jack A Schalken, Egbert Oosterwijk, Onno van Hooij & Lambertus A Kiemeney
  36. Pulmonary Diseases, Radboud University Nijmegen Medical Centre, PO Box 9101, HB, 6500, Nijmegen, The Netherlands
    Henricus F M van der Heijden
  37. Department of Pulmonary Medicine, Rijnstate Hospital, Arnhem, The Netherlands
    Hans J Smit
  38. Department of Pulmonary Diseases, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, Nijmegen, 6532 SZ, The Netherlands
    René A Termeer
  39. Department of Oncology, Sahlgrenska University Hospital, Goteborg, S-413 45, Sweden
    Gunnar Steineck
  40. Department of General Practice, Maastricht University, MD, 6200, Maastricht, The Netherlands
    Frank Buntinx
  41. Department of Epidemiology and Public Health, Imperial College, London, W2 1PG, UK
    Paolo Vineis
  42. Section of Experimental Oncology, Leeds Institute of Molecular Medicine, St. James's University Hospital, Leeds, LS9 7TF, UK
    Anne E Kiltie
  43. Department of Medicine, Landspitali-University Hospital, Reykjavik, 101, Iceland
    Steinn Jonsson

Authors

  1. Thorunn Rafnar
    You can also search for this author inPubMed Google Scholar
  2. Patrick Sulem
    You can also search for this author inPubMed Google Scholar
  3. Simon N Stacey
    You can also search for this author inPubMed Google Scholar
  4. Frank Geller
    You can also search for this author inPubMed Google Scholar
  5. Julius Gudmundsson
    You can also search for this author inPubMed Google Scholar
  6. Asgeir Sigurdsson
    You can also search for this author inPubMed Google Scholar
  7. Margret Jakobsdottir
    You can also search for this author inPubMed Google Scholar
  8. Hafdis Helgadottir
    You can also search for this author inPubMed Google Scholar
  9. Steinunn Thorlacius
    You can also search for this author inPubMed Google Scholar
  10. Katja K H Aben
    You can also search for this author inPubMed Google Scholar
  11. Thorarinn Blöndal
    You can also search for this author inPubMed Google Scholar
  12. Gudmar Thorleifsson
    You can also search for this author inPubMed Google Scholar
  13. Kristleifur Kristjansson
    You can also search for this author inPubMed Google Scholar
  14. Kristin Thorisdottir
    You can also search for this author inPubMed Google Scholar
  15. Halla Skuladottir
    You can also search for this author inPubMed Google Scholar
  16. Tomas Gudbjartsson
    You can also search for this author inPubMed Google Scholar
  17. Helgi J Isaksson
    You can also search for this author inPubMed Google Scholar
  18. Kristrun R Benediktsdottir
    You can also search for this author inPubMed Google Scholar
  19. Karl Olafsson
    You can also search for this author inPubMed Google Scholar
  20. Anna Salvarsdottir
    You can also search for this author inPubMed Google Scholar
  21. Hjordis Bjarnason
    You can also search for this author inPubMed Google Scholar
  22. Margret Asgeirsdottir
    You can also search for this author inPubMed Google Scholar
  23. Kari T Kristinsson
    You can also search for this author inPubMed Google Scholar
  24. Sigurborg Matthiasdottir
    You can also search for this author inPubMed Google Scholar
  25. Steinunn G Sveinsdottir
    You can also search for this author inPubMed Google Scholar
  26. Silvia Polidoro
    You can also search for this author inPubMed Google Scholar
  27. Veronica Höiom
    You can also search for this author inPubMed Google Scholar
  28. Rafael Botella-Estrada
    You can also search for this author inPubMed Google Scholar
  29. Kari Hemminki
    You can also search for this author inPubMed Google Scholar
  30. Peter Rudnai
    You can also search for this author inPubMed Google Scholar
  31. D Timothy Bishop
    You can also search for this author inPubMed Google Scholar
  32. Marcello Campagna
    You can also search for this author inPubMed Google Scholar
  33. Eliane Kellen
    You can also search for this author inPubMed Google Scholar
  34. Maurice P Zeegers
    You can also search for this author inPubMed Google Scholar
  35. Petra de Verdier
    You can also search for this author inPubMed Google Scholar
  36. Ana Ferrer
    You can also search for this author inPubMed Google Scholar
  37. Dolores Isla
    You can also search for this author inPubMed Google Scholar
  38. Maria Jesus Vidal
    You can also search for this author inPubMed Google Scholar
  39. Raquel Andres
    You can also search for this author inPubMed Google Scholar
  40. Berta Saez
    You can also search for this author inPubMed Google Scholar
  41. Pablo Juberias
    You can also search for this author inPubMed Google Scholar
  42. Javier Banzo
    You can also search for this author inPubMed Google Scholar
  43. Sebastian Navarrete
    You can also search for this author inPubMed Google Scholar
  44. Alejandro Tres
    You can also search for this author inPubMed Google Scholar
  45. Donghui Kan
    You can also search for this author inPubMed Google Scholar
  46. Annika Lindblom
    You can also search for this author inPubMed Google Scholar
  47. Eugene Gurzau
    You can also search for this author inPubMed Google Scholar
  48. Kvetoslava Koppova
    You can also search for this author inPubMed Google Scholar
  49. Femmie de Vegt
    You can also search for this author inPubMed Google Scholar
  50. Jack A Schalken
    You can also search for this author inPubMed Google Scholar
  51. Henricus F M van der Heijden
    You can also search for this author inPubMed Google Scholar
  52. Hans J Smit
    You can also search for this author inPubMed Google Scholar
  53. René A Termeer
    You can also search for this author inPubMed Google Scholar
  54. Egbert Oosterwijk
    You can also search for this author inPubMed Google Scholar
  55. Onno van Hooij
    You can also search for this author inPubMed Google Scholar
  56. Eduardo Nagore
    You can also search for this author inPubMed Google Scholar
  57. Stefano Porru
    You can also search for this author inPubMed Google Scholar
  58. Gunnar Steineck
    You can also search for this author inPubMed Google Scholar
  59. Johan Hansson
    You can also search for this author inPubMed Google Scholar
  60. Frank Buntinx
    You can also search for this author inPubMed Google Scholar
  61. William J Catalona
    You can also search for this author inPubMed Google Scholar
  62. Giuseppe Matullo
    You can also search for this author inPubMed Google Scholar
  63. Paolo Vineis
    You can also search for this author inPubMed Google Scholar
  64. Anne E Kiltie
    You can also search for this author inPubMed Google Scholar
  65. José I Mayordomo
    You can also search for this author inPubMed Google Scholar
  66. Rajiv Kumar
    You can also search for this author inPubMed Google Scholar
  67. Lambertus A Kiemeney
    You can also search for this author inPubMed Google Scholar
  68. Michael L Frigge
    You can also search for this author inPubMed Google Scholar
  69. Thorvaldur Jonsson
    You can also search for this author inPubMed Google Scholar
  70. Hafsteinn Saemundsson
    You can also search for this author inPubMed Google Scholar
  71. Rosa B Barkardottir
    You can also search for this author inPubMed Google Scholar
  72. Eirikur Jonsson
    You can also search for this author inPubMed Google Scholar
  73. Steinn Jonsson
    You can also search for this author inPubMed Google Scholar
  74. Jon H Olafsson
    You can also search for this author inPubMed Google Scholar
  75. Jeffrey R Gulcher
    You can also search for this author inPubMed Google Scholar
  76. Gisli Masson
    You can also search for this author inPubMed Google Scholar
  77. Daniel F Gudbjartsson
    You can also search for this author inPubMed Google Scholar
  78. Augustine Kong
    You can also search for this author inPubMed Google Scholar
  79. Unnur Thorsteinsdottir
    You can also search for this author inPubMed Google Scholar
  80. Kari Stefansson
    You can also search for this author inPubMed Google Scholar

Contributions

The study was designed and results were interpreted by T.R., P.S., S.N.S., F.G., J.G., J.R.G., D.F.G., A.K., S.T., U.T. and K.S. Statistical analysis was carried out by P.S., F.G., D.F.G., M.L.F., G.T. and A.K. Subject ascertainment, recruitment, biological material collection and collection of clinical and lifestyle information was organized and carried out by T.E.T., K. Kristjansson, S.G.S., R.R., B. Sigurgeirsson, K.T., J.H.O., S.J., H.H., T.G., H.J.I., E.J., T.J., G.V.E., R.B.B., K.R.B., B.A.A., H. Skuladottir, K.O., A. Salvarsdottir, H. Saemundsson, J.H., V.H., E.N., S. Polidoro, S. Porru, R.B.-E., R.K., K.H., P.R., K. Koppova, E.G., G.S., D.T.B., A.E.K., M.C., E.K., M.P.Z., P.V., P.d.V., G. Matullo, A.F., D.I., M.J.V., R.A., B. Saez, P.J., J.B., S.N., A.T., D.K., A.L., F.d.V., F.B., W.J.C., J.A.S., H.F.M.v.d.H., H.J.S., R.A.T., E.O., O.v.H., K.K.H.A., J.I.M., L.A.K. Principal collaborators for the non-Icelandic populations were L.A.K. (The Netherlands), J.I.M. (Zaragoza, Spain), A.E.K. (UK), G. Matullo and P.V. (Torino), S.P. (Brescia), M.P.Z. and F.B. (Belgium), R.K. (Eastern Europe), G.S. (bladder cancer, Sweden), J.H. (melanoma, Sweden), E.N. (Valencia, Spain) and W.J.C. (Chicago, USA). Genotyping and laboratory experiments were carried out by A. Sigurdsson, T.B., M.J., H.H., H.B., M.A., K.T.K. and S.M. Bioinformatic analysis was carried out by P.S., T.R., A. Sigurdsson, T.E.T., G. Masson, T.B. and G.T. Authors T.R., P.S., D.F.G., A.K., U.T. and K.S. drafted the manuscript. All authors contributed to the final version of the paper.

Corresponding authors

Correspondence toThorunn Rafnar or Kari Stefansson.

Ethics declarations

Competing interests

The authors from deCODE Genetics are shareholders in deCODE Genetics Inc. and therefore declare competing financial interest.

Supplementary information

Rights and permissions

About this article

Cite this article

Rafnar, T., Sulem, P., Stacey, S. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.Nat Genet 41, 221–227 (2009). https://doi.org/10.1038/ng.296

Download citation